Latest Leverage News

Brightstar Resources has upgraded Mineral Resources at its Menzies Gold Project by 22%, significantly expanding its Indicated gold ounces and setting the stage for near-term mining development. The updated estimates underpin the upcoming Goldfields DFS 2.0 and a targeted Final Investment Decision in early 2026.

South Harz Potash has submitted three new exploration licence applications in Sweden’s Värmland Province, significantly expanding its copper-gold project area near the existing Glava 100 site.

Ore Resources Ltd has raised A$7.5 million through an oversubscribed equity placement to accelerate gold exploration at its Coolgardie and Randalls projects in Western Australia. The funds will underpin an expanded drilling program targeting key prospects in 2026.

Aumake Limited has raised $1.5 million through a share placement to strengthen inventory and expand its footprint in China, signaling renewed growth ambitions under a refreshed board.

Argenica Therapeutics’ AI-powered reanalysis of its Phase 2 trial reveals significant efficacy of ARG-007 in severe acute ischemic stroke patients, highlighting improved functional outcomes and reduced brain damage.

Emyria Limited is scaling up its Perth Empax clinic with increased therapist approvals and treatment rooms, setting the stage for broader national clinical growth next year.

Pantera Minerals has launched trading on the OTCQB Venture Market under ticker PTMLF, broadening its reach to U.S. investors and advancing its critical minerals exploration in Arkansas. This move complements its ASX listing and positions the company at the forefront of America’s push for secure domestic supply chains.

Prairie Lithium has locked in a decade-long agreement to supply lithium-bearing crystallite to Hydro Lithium’s South Korean refinery, marking a strategic step in its commercial-scale production and market entry.

Bioxyne Limited has secured a pioneering manufacturing and supply agreement to enter the emerging medicinal cannabis markets of Costa Rica and Panama, positioning itself as a first mover with promising revenue potential.

Brazilian Rare Earths Limited’s scoping study confirms the Amargosa Bauxite-Gallium Project as a large-scale, capital-efficient direct-ship bauxite operation with robust economic returns and strategic market positioning.

Norwest Minerals updates its West Arunta exploration strategy following a doubling of silver prices and a high-grade discovery at Dales Gossan, setting the stage for a major 2026 drilling campaign.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.